An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test designed to predict men at risk of developing prostate cancer.
US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen's Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
Following on from Dr Jim Golby’s comments only last week, David Garmon-Jones, co-chair of the competition’s executive steering group (ESG) is also calling on all pharma sales professionals to get involved in the competition.
The Competition Appeal Tribunal in the UK has overturned a £90 million fine for Pfizer and Flynn Pharma issued by the Competition and Markets Authority for charging unfair prices for phenytoin sodium capsules.
MSD’s Keytruda will be routinely available on the NHS for specific patients with previously untreated metastatic non-small-cell lung cancer, after NHS England struck a deal with the company, endorsed by NICE, to ensure its cost-effectiveness.